Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2012 08:30 ET | Source: PositiveID Corporation

PositiveID Corporation Announces First Quarter 2012 Accomplishments: Positions Itself for $3 Billion BioWatch Contract and Advances the Development of Its Diabetes Management Products

DELRAY BEACH, Fla., April 2, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes...
March 05, 2012 08:00 ET | Source: PositiveID Corporation

PositiveID Corporation Finalizes First-in-Class Development of a Fully Synthetic Glucose Sensing System, a Critical Component of an Artificial Pancreas

DELRAY BEACH, Fla., March 5, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today that it has...
February 13, 2012 08:00 ET | Source: PositiveID Corporation

PositiveID Achieves Positive Preliminary Results From Diabetes Research Institute Study at the University of Miami

DELRAY BEACH, Fla., Feb. 13, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today positive...
August 17, 2011 16:39 ET | Source: PositiveID Corporation

PositiveID Corporation Successfully Completes Phase II of Its GlucoChip Glucose-Sensing Microchip for Patients With Diabetes

Laboratory testing proves glucose-sensing system produces a measurable response to changing glucose levels in human blood matrix Companies publish results of testing in white paper, available at...
July 14, 2011 08:30 ET | Source: PositiveID Corporation

PositiveID Corporation Successfully Completes Development of Its Continuous Glucose Sensor to Accurately Measure Glucose Levels in Human Blood

DELRAY BEACH, Fla., July 14, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (Nasdaq:PSID), a developer of medical technologies for diabetes management, clinical...